Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2018 ISPAD临床实践共识指南：儿童和青少年1型糖尿病的分期

2018-07-26 国际儿童青少年糖尿病协会 Pediatr Diabetes. 2018 Jul 26.

1型糖尿病分期

2018年7月，国际儿童青少年糖尿病协会(ISPAD)发布了儿童和青少年1型糖尿病的分期共识指南，指南主要更新点如下：糖尿病新的分类改为为1-3阶段，预测1型糖尿病的工具包括遗传风险评分，更新了干预试验信息，包括一级预防和1和2阶段糖尿病。

中文标题：

2018 ISPAD临床实践共识指南：儿童和青少年1型糖尿病的分期

英文标题：

ISPAD Clinical Practice Consensus Guidelines 2018 Stages of type 1 diabetes in children and adolescents

发布机构：

国际儿童青少年糖尿病协会

发布日期：

2018-07-26

简要介绍：

2018年7月，国际儿童青少年糖尿病协会(ISPAD)发布了儿童和青少年1型糖尿病的分期共识指南，指南主要更新点如下：糖尿病新的分类改为为1-3阶段，预测1型糖尿病的工具包括遗传风险评分，更新了干预试验信息，包括一级预防和1和2阶段糖尿病。 

拓展指南：与糖尿病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ISPAD临床实践共识指南：儿童和青少年1型糖尿病的分期)] GetToolGuiderByIdResponse(projectId=1, id=1ec4f1c0016223b5, title=2018 ISPAD临床实践共识指南：儿童和青少年1型糖尿病的分期, enTitle=ISPAD Clinical Practice Consensus Guidelines 2018 Stages of type 1 diabetes in children and adolescents, guiderFrom=Pediatr Diabetes. 2018 Jul 26., authorId=null, author=, summary=2018年7月，国际儿童青少年糖尿病协会(ISPAD)发布了儿童和青少年1型糖尿病的分期共识指南，指南主要更新点如下：糖尿病新的分类改为为1-3阶段，预测1型糖尿病的工具包括遗传风险评分，更新了干预试验信息，包括一级预防和1和2阶段糖尿病。 , cover=, journalId=null, articlesId=null, associationId=417, associationName=国际儿童青少年糖尿病协会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jul 26 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年7月，国际儿童青少年糖尿病协会(ISPAD)发布了儿童和青少年1型糖尿病的分期共识指南，指南主要更新点如下：糖尿病新的分类改为为1-3阶段，预测1型糖尿病的工具包括遗传风险评分，更新了干预试验信息，包括一级预防和1和2阶段糖尿病。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>糖尿病</font>相关指南：</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=9901e1c001620eca" title="2018 ISPAD临床实践共识指南：需要手术的儿童和青少年糖尿病患者的管理" target=_blank>2018 ISPAD临床实践共识指南：需要手术的儿童和青少年糖尿病患者的管理</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=61de01c001606236" title="2018 JBDS-IP指南：糖尿病住院患者的自我管理" target=_blank>2018 JBDS-IP指南：糖尿病住院患者的自我管理</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=0ba401c001603883" title="糖尿病检验诊断报告模式专家共识" target=_blank>糖尿病检验诊断报告模式专家共识</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=6f8a11c0016025f4" title="老年人糖尿病前期干预指南" target=_blank>老年人糖尿病前期干预指南</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=bb86e1c001601155" title="2018 营养和饮食学会循证实践指南：妊娠糖尿病" target=_blank>2018 营养和饮食学会循证实践指南：妊娠糖尿病</a></li> 更多信息请点击：<a href="//www.sandwebs.com/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85" target=_blank>有关糖尿病更多指南</a></ul>, tagList=[TagDto(tagId=2054, tagName=1型糖尿病), TagDto(tagId=3417, tagName=分期)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8239, appHits=224, showAppHits=1, pcHits=4984, showPcHits=3660, likes=168, shares=12, comments=4, approvalStatus=1, publishedTime=Mon Jul 30 21:44:47 CST 2018, publishedTimeString=2018-07-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Jul 30 21:44:47 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 14:26:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ISPAD临床实践共识指南：儿童和青少年1型糖尿病的分期)])
2018 ISPAD临床实践共识指南：儿童和青少年1型糖尿病的分期
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=335273, encodeId=47813352e3fe, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue Jul 31 08:14:47 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335210, encodeId=3b8a335210cc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Mon Jul 30 23:28:28 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335202, encodeId=4d24335202e4, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 30 23:16:31 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335185, encodeId=fe3d33518597, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Jul 30 22:23:34 CST 2018, time=2018-07-30, status=1, ipAttribution=)]
    2018-07-31 龙胆草

    学习谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=335273, encodeId=47813352e3fe, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue Jul 31 08:14:47 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335210, encodeId=3b8a335210cc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Mon Jul 30 23:28:28 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335202, encodeId=4d24335202e4, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 30 23:16:31 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335185, encodeId=fe3d33518597, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Jul 30 22:23:34 CST 2018, time=2018-07-30, status=1, ipAttribution=)]
    2018-07-30 happsf

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=335273, encodeId=47813352e3fe, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue Jul 31 08:14:47 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335210, encodeId=3b8a335210cc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Mon Jul 30 23:28:28 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335202, encodeId=4d24335202e4, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 30 23:16:31 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335185, encodeId=fe3d33518597, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Jul 30 22:23:34 CST 2018, time=2018-07-30, status=1, ipAttribution=)]
    2018-07-30 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=335273, encodeId=47813352e3fe, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue Jul 31 08:14:47 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335210, encodeId=3b8a335210cc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Mon Jul 30 23:28:28 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335202, encodeId=4d24335202e4, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 30 23:16:31 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335185, encodeId=fe3d33518597, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Jul 30 22:23:34 CST 2018, time=2018-07-30, status=1, ipAttribution=)]
    2018-07-30 惠映实验室

    学习了，谢谢分享。

    0

相关指南

2017 共识声明：1型糖尿病的运动管理

国外内分泌相关专家小组（统称） · 2017-05-01

2015 NICE指南：成人1型糖尿病的诊断和管理（NG.17）

暂未更新 · 2015-08-26

2015 JDRF/TES/ADA科学声明：1型糖尿病的前驱症状

美国糖尿病学会(ADA,American Diabetes Association) · 2015-09-20

Baidu
map
Baidu
map
Baidu
map